SNNAQ (Sienna Biopharmaceuticals) Net Margin %: 0.00% (As of Sep. 2019)


What is Sienna Biopharmaceuticals Net Margin %?

Sienna Biopharmaceuticals SNNAQ -99.00% Net Margin % is 0.00% as of Sep. 2019.

Net margin is calculated as Net Income divided by its Revenue. Sienna Biopharmaceuticals's Net Income for the three months ended in Sep. 2019 was $-3.97 Mil. Sienna Biopharmaceuticals's Revenue for the three months ended in Sep. 2019 was $0.00 Mil. Therefore, Sienna Biopharmaceuticals's net margin for the quarter that ended in Sep. 2019 was 0.00%.

The historical rank and industry rank for Sienna Biopharmaceuticals's Net Margin % or its related term are showing as below:


SNNAQ's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Sienna Biopharmaceuticals  (OTCPK:SNNAQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Sienna Biopharmaceuticals Net Margin % Related Terms

Sienna Biopharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals Net Margin % Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
Net Margin %
0.00 0.00 0.00 0.00

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SNNAQ vs GTHR, PPCB, HSTC: Net Margin % Comparison

For the Biotechnology subindustry, Sienna Biopharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sienna Biopharmaceuticals Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sienna Biopharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sienna Biopharmaceuticals's Net Margin % falls into.


Sienna Biopharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sienna Biopharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2018 is calculated as

Net Margin=Net Income (A: Dec. 2018 )/Revenue (A: Dec. 2018 )
=-73.471/0
= %

Sienna Biopharmaceuticals's Net Margin for the quarter that ended in Sep. 2019 is calculated as

Net Margin=Net Income (Q: Sep. 2019 )/Revenue (Q: Sep. 2019 )
=-3.97/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Sienna Biopharmaceuticals (SNNAQ) has a Net Margin % of 0.00% as of Sep. 2019. Net margin is the ratio of total net income to net sales. View historical data on Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' Net Margin % too high?
Sienna Biopharmaceuticals' current Net Margin % is 0.00%.
How does Sienna Biopharmaceuticals' Net Margin % compare to GTHR and PPCB?
Sienna Biopharmaceuticals' Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current Net Margin % is 0.00% as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.